3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Dermatologic
1
Conditions
Stress Disorders, Post-Traumatic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obsessive-Compulsive Disorder
1
Interventions
Cyclophosphamide
47
Rituximab
34
Exercise
25
fludarabine phosphate
24
Methotrexate
24
Blood Specimen Collection
23
Vincristine
21
Cytarabine
21
Radiotherapy
20
Filgrastim
19
Peripheral Blood Stem Cell Transplantation
18
Whole-Body Irradiation
17
Prednisone
16
Melphalan
16
Etoposide
16
Cyclosporine
16
Methods
15
Dexamethasone
15
Busulfan
15
Antilymphocyte Serum
15
fludarabine
14
Doxorubicin
14
Educational Status
13
Mycophenolic Acid
12
Magnetic Resonance Spectroscopy
11
Early Intervention, Educational
11
Therapeutics
10
Surveys and Questionnaires
9
Standard of Care
9
Prednisolone
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Eye Movement Desensitization Reprocessing
×
Lymphoid
×
Clear all
NCT06110702
2024-04-16
MDL
University of Pisa
Phase NA
Completed
287 enrolled